Trials / Unknown
UnknownNCT02199275
Effect of General Anesthesia on Enterocyte Damage
Impact of General Anesthesia on Enterocyte Damage
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 50 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Besancon · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
During non urgent surgery, general anesthesia might induce enterocyte damage. I-FABP is a performant biomarker of enterocyte damage. We aimed to study whether patient ongoing general anesthesia for non-urgent surgery have an elevation of plasma I-FABP concentration.
Detailed description
Inclusion criteria * Indication of non-urgent surgery * General anesthesia protocol using propofol and remifentanyl * One half of the patients have a history of ischemic arteriopathy * One half of the patients have no history of ischemic arteriopathy Exclusion criteria * Age \< 18 years old * Pregnant Primary objective Is there a significant elevation of I-FABP between the pre-anesthesic period and 11 minutes after induction of general anesthesia ? Secondary objectives 1. Is I-FABP elevation higher among patients with history of patent arteriopathy ? 2. Is I-FABP elevation higher among patients presenting with hypotension during anesthesia ?
Conditions
Timeline
- Start date
- 2013-08-01
- Primary completion
- 2014-08-01
- Completion
- 2014-08-01
- First posted
- 2014-07-24
- Last updated
- 2014-07-24
Locations
1 site across 1 country: France
Source: ClinicalTrials.gov record NCT02199275. Inclusion in this directory is not an endorsement.